Annual D&A
$229.40 M
-$10.78 M-4.49%
31 December 2023
Summary:
Amneal Pharmaceuticals annual depreciation & amortization is currently $229.40 million, with the most recent change of -$10.78 million (-4.49%) on 31 December 2023. During the last 3 years, it has fallen by -$5.99 million (-2.54%). AMRX annual D&A is now -4.49% below its all-time high of $240.18 million, reached on 31 December 2022.AMRX Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$58.96 M
+$3.39 M+6.10%
30 September 2024
Summary:
Amneal Pharmaceuticals quarterly depreciation & amortization is currently $58.96 million, with the most recent change of +$3.39 million (+6.10%) on 30 September 2024. Over the past year, it has increased by +$1.75 million (+3.07%). AMRX quarterly D&A is now -4.30% below its all-time high of $61.61 million, reached on 30 September 2022.AMRX Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$226.99 M
+$1.75 M+0.78%
30 September 2024
Summary:
Amneal Pharmaceuticals TTM depreciation & amortization is currently $226.99 million, with the most recent change of +$1.75 million (+0.78%) on 30 September 2024. Over the past year, it has dropped by -$6.53 million (-2.80%). AMRX TTM D&A is now -5.62% below its all-time high of $240.51 million, reached on 31 March 2023.AMRX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AMRX Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -4.5% | +3.1% | -2.8% |
| 3 y3 years | -2.5% | -2.0% | -2.2% |
| 5 y5 years | +67.0% | +10.5% | +13.3% |
AMRX Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -4.5% | at low | -4.3% | +6.2% | -5.6% | +0.8% |
| 5 y | 5 years | -4.5% | +67.0% | -4.3% | +10.5% | -5.6% | +13.3% |
| alltime | all time | -4.5% | +594.8% | -4.3% | +299.7% | -5.6% | +1438.8% |
Amneal Pharmaceuticals Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $58.96 M(+6.1%) | $226.99 M(+0.8%) |
| June 2024 | - | $55.57 M(+0.1%) | $225.24 M(-0.7%) |
| Mar 2024 | - | $55.53 M(-2.5%) | $226.78 M(-1.1%) |
| Dec 2023 | $229.40 M(-4.5%) | $56.93 M(-0.5%) | $229.40 M(-1.8%) |
| Sept 2023 | - | $57.21 M(+0.2%) | $233.52 M(-1.9%) |
| June 2023 | - | $57.11 M(-1.8%) | $237.93 M(-1.1%) |
| Mar 2023 | - | $58.15 M(-4.8%) | $240.51 M(+0.1%) |
| Dec 2022 | $240.18 M(+2.9%) | $61.06 M(-0.9%) | $240.18 M(-0.1%) |
| Sept 2022 | - | $61.61 M(+3.2%) | $240.30 M(+0.6%) |
| June 2022 | - | $59.70 M(+3.3%) | $238.88 M(+1.4%) |
| Mar 2022 | - | $57.81 M(-5.5%) | $235.67 M(+1.0%) |
| Dec 2021 | $233.41 M | $61.18 M(+1.7%) | $233.41 M(+0.6%) |
| Sept 2021 | - | $60.19 M(+6.5%) | $232.10 M(+0.4%) |
| June 2021 | - | $56.49 M(+1.7%) | $231.27 M(-0.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $55.55 M(-7.2%) | $232.85 M(-1.1%) |
| Dec 2020 | $235.39 M(+13.6%) | $59.87 M(+0.9%) | $235.39 M(+2.4%) |
| Sept 2020 | - | $59.36 M(+2.2%) | $229.82 M(+2.7%) |
| June 2020 | - | $58.07 M(-0.0%) | $223.82 M(+3.4%) |
| Mar 2020 | - | $58.08 M(+7.0%) | $216.45 M(+4.4%) |
| Dec 2019 | $207.24 M(+50.8%) | $54.30 M(+1.8%) | $207.24 M(+3.4%) |
| Sept 2019 | - | $53.36 M(+5.2%) | $200.43 M(+5.4%) |
| June 2019 | - | $50.71 M(+3.8%) | $190.08 M(+10.8%) |
| Mar 2019 | - | $48.87 M(+2.9%) | $171.52 M(+24.8%) |
| Dec 2018 | $137.40 M(+199.1%) | $47.49 M(+10.4%) | $137.40 M(+52.8%) |
| Sept 2018 | - | $43.01 M(+33.8%) | $89.91 M(+91.7%) |
| June 2018 | - | $32.15 M(+117.9%) | $46.90 M(+217.9%) |
| Mar 2018 | - | $14.75 M | $14.75 M |
| Dec 2017 | $45.94 M(+39.1%) | - | - |
| Dec 2016 | $33.02 M | - | - |
FAQ
- What is Amneal Pharmaceuticals annual depreciation & amortization?
- What is the all time high annual D&A for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals annual D&A year-on-year change?
- What is Amneal Pharmaceuticals quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals quarterly D&A year-on-year change?
- What is Amneal Pharmaceuticals TTM depreciation & amortization?
- What is the all time high TTM D&A for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals TTM D&A year-on-year change?
What is Amneal Pharmaceuticals annual depreciation & amortization?
The current annual D&A of AMRX is $229.40 M
What is the all time high annual D&A for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high annual depreciation & amortization is $240.18 M
What is Amneal Pharmaceuticals annual D&A year-on-year change?
Over the past year, AMRX annual depreciation & amortization has changed by -$10.78 M (-4.49%)
What is Amneal Pharmaceuticals quarterly depreciation & amortization?
The current quarterly D&A of AMRX is $58.96 M
What is the all time high quarterly D&A for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high quarterly depreciation & amortization is $61.61 M
What is Amneal Pharmaceuticals quarterly D&A year-on-year change?
Over the past year, AMRX quarterly depreciation & amortization has changed by +$1.75 M (+3.07%)
What is Amneal Pharmaceuticals TTM depreciation & amortization?
The current TTM D&A of AMRX is $226.99 M
What is the all time high TTM D&A for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high TTM depreciation & amortization is $240.51 M
What is Amneal Pharmaceuticals TTM D&A year-on-year change?
Over the past year, AMRX TTM depreciation & amortization has changed by -$6.53 M (-2.80%)